The main shareholders in Medical technology company Bactiguard Holding AB broaden the shareholder base and increase the free float in the company's share through a secondary sale of existing shares to three Swedish institutional owners. The transaction comprises 6.63 million B-shares at the price of SEK 39 per share and the total value amounts to SEK 258.6m.
